Applied Research in Dermatology and Bartonella Infection Laboratory, University of Campinas-UNICAMP; Campinas, Sao Paulo, Brazil.
Hematology and Hemotherapy Center, University of Campinas-UNICAMP, Campinas, Sao Paulo, Brazil.
PLoS Negl Trop Dis. 2023 Jun 1;17(6):e0011336. doi: 10.1371/journal.pntd.0011336. eCollection 2023 Jun.
The Bartonella genus consists of neglected pathogens associated with potentially transfusional-transmitted and fatal human diseases. We aimed to evaluate Bartonella sp. prevalence in 500 blood donors and compare the results with the data already published about these samples. We used molecular diagnostic methods to detect Bartonella sp.-DNA from blood and liquid culture samples: (A) conventional PCR for two gene regions, the ITS targeting the genus Bartonella and the specific gltA Bartonella henselae; (B) nested PCR for the ftsZ gene and (C) qualitative real-time PCR for the gltA gene, both B. henselae specific. We obtained 30/500 (6%) DNA detections from the blood samples; 77/500 (15.4%) DNA detections from liquid culture samples and five (1%) samples had DNA detection from both. In total, we detected B. henselae DNA from 102/500 (20.4%) donors. The samples used in this study had already been submitted for Bartonella sp.-DNA detection using only a conventional PCR in liquid culture. Sixteen samples (3.2%) were positive previously, and from these 16 samples, 13 were negative in the new investigation. We concluded that the use of liquid culture combined with different molecular tests increases the possibility of detecting Bartonella sp.-DNA, but the tests do not avoid false-negative results. More than a fifth of blood donors had at least one PCR that detected Bartonella sp.-DNA among the eight molecular reactions performed now (four reactions in whole blood and four in liquid culture). Seven percent had B. henselae-DNA detection for two or more distinct regions. Considering the results obtained previously, the DNA of Bartonella spp. was detected or the agent isolated in 23% of analyzed blood donors. The results establish that the low bacteremia and the fastidious characteristics of the bacterium are challenges to laboratory diagnosis and can make it difficult to confirm the infection in patients with bartonelloses.
巴尔通体属由一些被忽视的病原体组成,这些病原体与潜在的可输血传播和致命的人类疾病有关。我们旨在评估 500 名献血者中巴尔通体属的流行率,并将结果与已发表的这些样本数据进行比较。我们使用分子诊断方法从血液和液体培养样本中检测巴尔通体属-DNA:(A)针对巴尔通体属的 ITS 靶向基因和特定的 gltA 汉赛巴尔通体的常规 PCR;(B)ftsZ 基因的嵌套 PCR 和 (C)gltA 基因的定性实时 PCR,均为汉赛巴尔通体特异性。我们从血液样本中获得 30/500(6%)的 DNA 检测结果;从液体培养样本中获得 77/500(15.4%)的 DNA 检测结果,从 5 个样本中同时获得了 DNA 检测结果。总共从 500 名献血者中检测到 102 名(20.4%)携带汉赛巴尔通体 DNA。本研究使用的样本已经在液体培养中仅使用常规 PCR 进行了巴尔通体属-DNA 检测。16 个样本(3.2%)之前呈阳性,在这 16 个样本中,有 13 个在新的调查中呈阴性。我们得出结论,使用液体培养并结合不同的分子检测可以增加检测巴尔通体属-DNA 的可能性,但这些检测并不能避免假阴性结果。在现在进行的八项分子反应中,超过五分之一的献血者至少有一项 PCR 检测到巴尔通体属-DNA(全血四项反应,液体培养四项反应)。有 7%的献血者有两种或两种以上不同区域的汉赛巴尔通体 DNA 检测结果。考虑到之前获得的结果,在 23%的分析献血者中检测到巴尔通体属的 DNA 或分离到该菌。这些结果表明,低菌血症和细菌的苛刻特性是实验室诊断的挑战,可能使巴通体病患者的感染难以确诊。